Dicle Aslan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dicle Aslan has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Dilek Efe Arslan
Erciyes Universitesi
3 shared publications - Mustafa Tarkan Aksozen
ERCİYES ÜNİVERSİTESİ, TIP FAKÜLTESİ
2 shared publications - Nazan Kiliç Akça
İZMİR BAKIRÇAY ÜNİVERSİTESİ
2 shared publications Alparslan Serarslan
Ondokuz Mayis University Faculty of Medicine: Ondokuz Mayis Universitesi Tip Fakultesi
1 shared publicationBerna Akkus Yıldırım
Prof Dr Cemil Taşcıoğlu Şehir Hastanesi: TC Saglik Bakanligi Adiyaman Istanbul Prof Dr Cemil Tascioglu Sehir Hastanesi
1 shared publicationEda Erdis
Cumhuriyet University: Sivas Cumhuriyet Universitesi
1 shared publication
Latest Publications
- 30 September 2026
- Published by Dokuz Eyul Universitesi Saglik Bilimleri Enstitusu in Journal of Basic and Clinical Health Sciences
- Vol. 10 (3) , 435-445
Ionising Radiation Suppresses rAPC-Induced NLRP3 Expression and Associated Signaling in Rat Brain: Evidence for a Radiation-Sensitive Molecular Phenotype
Purpose: Recombinant activated protein C (rAPC) is widely regarded as an anti-inflammatory and cytoprotective agent; however, its molecular effects in the irradiated central nervous system remain poorly characterized. This study aims to characterize the gene expression profile triggered by rAPC in the rat brain and to evaluate how ionizing radiation alters these molecular (apoptotic and neuroinflammatory) responses.Material and Methods: Male Wistar Albino rats were randomly assigned to four experimental groups: untreated control, total body irradiation (9 Gy, TBI), rAPC (0.4 mg/kg, intravenous) alone, and TBI followed by rAPC. Brain tissue was collected for gene expression analysis of apoptosis, neuroinflammation, and oxidative stress-related markers.Results: Five genes showed significant omnibus effects. BAX expression (ε² = 0.62) was significantly reduced by both irradiation and rAPC alone; the combination group showed higher BAX than the irradiation-only group, suggesting partial restoration by rAPC. BCL-2 was reduced by irradiation and p53 was reduced by rAPC alone (η² = 0.38). Strikingly, rAPC alone selectively upregulated NLRP3 inflammasome expression (p = 0.023) with a consistent directional increase in TNF-α, a pro-inflammatory activation signature absent in irradiated groups. No significant changes were observed in oxidative stress markers, COX-2, FGFR, or CASP3. Conclusion: These findings reveal a radiation-sensitive molecular phenotype for rAPC in rat brain tissue. rAPC alone upregulates Nlrp3 expression and associated signaling while simultaneously reducing P53 and Bax expression, defining a multifaceted molecular profile that is substantially modified in the irradiated context.
- 30 September 2026
- Published by Dokuz Eyul Universitesi Saglik Bilimleri Enstitusu in Journal of Basic and Clinical Health Sciences
- Vol. 10 (3) , 435-445
Ionising Radiation Suppresses rAPC-Induced NLRP3 Expression and Associated Signaling in Rat Brain: Evidence for a Radiation-Sensitive Molecular Phenotype
Purpose: Recombinant activated protein C (rAPC) is widely regarded as an anti-inflammatory and cytoprotective agent; however, its molecular effects in the irradiated central nervous system remain poorly characterized. This study aims to characterize the gene expression profile triggered by rAPC in the rat brain and to evaluate how ionizing radiation alters these molecular (apoptotic and neuroinflammatory) responses.Material and Methods: Male Wistar Albino rats were randomly assigned to four experimental groups: untreated control, total body irradiation (9 Gy, TBI), rAPC (0.4 mg/kg, intravenous) alone, and TBI followed by rAPC. Brain tissue was collected for gene expression analysis of apoptosis, neuroinflammation, and oxidative stress-related markers.Results: Five genes showed significant omnibus effects. BAX expression (ε² = 0.62) was significantly reduced by both irradiation and rAPC alone; the combination group showed higher BAX than the irradiation-only group, suggesting partial restoration by rAPC. BCL-2 was reduced by irradiation and p53 was reduced by rAPC alone (η² = 0.38). Strikingly, rAPC alone selectively upregulated NLRP3 inflammasome expression (p = 0.023) with a consistent directional increase in TNF-α, a pro-inflammatory activation signature absent in irradiated groups. No significant changes were observed in oxidative stress markers, COX-2, FGFR, or CASP3. Conclusion: These findings reveal a radiation-sensitive molecular phenotype for rAPC in rat brain tissue. rAPC alone upregulates Nlrp3 expression and associated signaling while simultaneously reducing P53 and Bax expression, defining a multifaceted molecular profile that is substantially modified in the irradiated context.
- Open Access
- 31 January 2026
- Published by Wiley in Perspectives in Psychiatric Care
- Vol. 2026 (1)
The Experiences of Stigma of Male Breast Cancer Patients: A Qualitative Research
Objective: This study aimed to explore the stigma experiences of male breast cancer patients, a group often overlooked due to the rarity of the disease. This research focuses on how these patients perceive and are affected by social stigma during and after treatment. Method: A qualitative phenomenological approach was adopted. The study included five male patients diagnosed with breast cancer, recruited from an oncology hospital in Central Anatolia, Turkey, between January and October 2023. Data were collected through semistructured interviews conducted via WhatsApp video calls. All interviews were audio‐recorded, transcribed verbatim, and analyzed thematically. The study followed the Consolidated Criteria for Reporting Qualitative Research (COREQ) checklist. Results: Participants initially attempted to hide the physical signs of their illness but later adapted to their condition. Challenges were reported in resuming normal life during and after treatment, including surgery, chemotherapy, and radiotherapy. While no significant stigma was perceived within hospital settings, participants expressed discomfort about receiving treatment in shared environments with female patients, particularly in waiting areas. These feelings were linked to gender roles and social perceptions. Conclusion: Although male breast cancer patients did not report stigma from healthcare professionals, they experienced emotional discomfort due to the predominantly female environment of breast cancer care. The findings emphasize the need to raise awareness of male breast cancer and to create healthcare environments sensitive to gender‐based experiences to support the psychosocial well‐being of male patients.
- 31 January 2026
- Published by Wiley in Perspectives in Psychiatric Care
- Vol. 2026 (1)
Open AccessThe Experiences of Stigma of Male Breast Cancer Patients: A Qualitative Research
Objective: This study aimed to explore the stigma experiences of male breast cancer patients, a group often overlooked due to the rarity of the disease. This research focuses on how these patients perceive and are affected by social stigma during and after treatment. Method: A qualitative phenomenological approach was adopted. The study included five male patients diagnosed with breast cancer, recruited from an oncology hospital in Central Anatolia, Turkey, between January and October 2023. Data were collected through semistructured interviews conducted via WhatsApp video calls. All interviews were audio‐recorded, transcribed verbatim, and analyzed thematically. The study followed the Consolidated Criteria for Reporting Qualitative Research (COREQ) checklist. Results: Participants initially attempted to hide the physical signs of their illness but later adapted to their condition. Challenges were reported in resuming normal life during and after treatment, including surgery, chemotherapy, and radiotherapy. While no significant stigma was perceived within hospital settings, participants expressed discomfort about receiving treatment in shared environments with female patients, particularly in waiting areas. These feelings were linked to gender roles and social perceptions. Conclusion: Although male breast cancer patients did not report stigma from healthcare professionals, they experienced emotional discomfort due to the predominantly female environment of breast cancer care. The findings emphasize the need to raise awareness of male breast cancer and to create healthcare environments sensitive to gender‐based experiences to support the psychosocial well‐being of male patients.
- 15 December 2025
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
- Vol. 15 (4) , 402-410
DOSIMETRIC ANALYSIS OF DEEP INSPIRATION BREATH HOLD TECHNIQUE ADAPTED TO TANGENTIAL-BASED VOLUMETRIC MODULATED ARC THERAPY FOR LEFT BREAST CANCER AFTER MASTECTOMY
Purpose: To evaluate the dosimetric properties of the deep inspiration breath hold (DIBH) technique adapted to tangential-based volumetric modulated arc therapy (TVMAT) in left breast cancer patients with mastectomy. Method: Forty-three patients who underwent mastectomy and received chest wall and regional lymph node irradiation were included in the study. Simulation computed tomography (CT) was performed in DIBH and free-breathing (FB). Two plans were created for each patient; DIBH-TVMAT and FB-TVMAT. Both plans were realized using a mono-isocentric technique with two partial arc rotations, and the same gantry angles were used.The standard fractionation schedule for each patient was set to 50 Gy in 25 fractions. Paired-sample T-test was used to evaluate the dosimetric parameters. Results: The comparison between FB-TVMAT and DIBH-TVMAT plans revealed mean heart doses of 8.9 Gy and 5.4 Gy, respectively (p=0.000). A 6.2% reduction was encountered in left lung volume receiving 5 Gy (V5) in the DIBH-TVMAT plan (p=0.01). A reduction of 1.3 Gy at a percentage of 28% was monitored in the mean dose of the right lung in DIBH-TVMAT (p=0.000). The mean right breast dose was 0.7 Gy lower in DIBH-TVMAT (p=0.000). Conclusion: The results support that the adaptation of DIBH to TVMAT allows an optimal target volume dose coverage as well as leads to significant dose reductions in the left lung, right lung, heart, LADCA, and right breast for the left breast cancer patients with mastectomy.
- 15 December 2025
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
- Vol. 15 (4) , 402-410
DOSIMETRIC ANALYSIS OF DEEP INSPIRATION BREATH HOLD TECHNIQUE ADAPTED TO TANGENTIAL-BASED VOLUMETRIC MODULATED ARC THERAPY FOR LEFT BREAST CANCER AFTER MASTECTOMY
Purpose: To evaluate the dosimetric properties of the deep inspiration breath hold (DIBH) technique adapted to tangential-based volumetric modulated arc therapy (TVMAT) in left breast cancer patients with mastectomy. Method: Forty-three patients who underwent mastectomy and received chest wall and regional lymph node irradiation were included in the study. Simulation computed tomography (CT) was performed in DIBH and free-breathing (FB). Two plans were created for each patient; DIBH-TVMAT and FB-TVMAT. Both plans were realized using a mono-isocentric technique with two partial arc rotations, and the same gantry angles were used.The standard fractionation schedule for each patient was set to 50 Gy in 25 fractions. Paired-sample T-test was used to evaluate the dosimetric parameters. Results: The comparison between FB-TVMAT and DIBH-TVMAT plans revealed mean heart doses of 8.9 Gy and 5.4 Gy, respectively (p=0.000). A 6.2% reduction was encountered in left lung volume receiving 5 Gy (V5) in the DIBH-TVMAT plan (p=0.01). A reduction of 1.3 Gy at a percentage of 28% was monitored in the mean dose of the right lung in DIBH-TVMAT (p=0.000). The mean right breast dose was 0.7 Gy lower in DIBH-TVMAT (p=0.000). Conclusion: The results support that the adaptation of DIBH to TVMAT allows an optimal target volume dose coverage as well as leads to significant dose reductions in the left lung, right lung, heart, LADCA, and right breast for the left breast cancer patients with mastectomy.
- Open Access
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Dosimetric comparison of IMRT, VMAT, and hybrid techniques in stereotactic body radiotherapy for adrenal metastases
Stereotactic body radiotherapy (SBRT) has emerged as a non-invasive alternative for the treatment of adrenal metastases, increasingly replacing traditional invasive approaches. However, its clinical application remains under investigation. The introduction of advanced radiotherapy techniques has further fueled interest in SBRT, necessitating comprehensive dosimetric evaluations to optimize treatment strategies. This study compares three distinct SBRT techniques: pure intensity-modulated radiotherapy (IMRT), pure volumetric modulated arc therapy (VMAT), and a hybrid approach combining VMAT and IMRT, utilizing flattening filter-free (FFF) photon beams. Treatment plans were assessed using dosimetric distributions, dose-volume histograms (DVH), homogeneity index (HI), and conformity index (CI). Repeated-measures analysis of variance (ANOVA) was performed, with statistical significance set at p < 0.05. Both VMAT and hybrid plans demonstrated superior CI and HI values compared to IMRT. However, the maximum dose (Dmax) to the planning target volume (PTV) was lower in the hybrid plan than in VMAT but comparable to IMRT. Additionally, critical organ dose analyses revealed that VMAT and hybrid plans achieved significantly lower doses in the renal cortex (Dmax and V17.5), duodenum (Dmax and V12.5), aorta (Dmax), and stomach (Dmax) compared to IMRT. The findings indicate that both VMAT and hybrid techniques outperform IMRT, offering improved plan quality and superior critical organ sparing. These results highlight the potential clinical advantages of VMAT and hybrid SBRT approaches in the treatment of adrenal metastases. Further clinical validation through large-scale studies is warranted to establish the optimal treatment strategy.
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Open AccessDosimetric comparison of IMRT, VMAT, and hybrid techniques in stereotactic body radiotherapy for adrenal metastases
Stereotactic body radiotherapy (SBRT) has emerged as a non-invasive alternative for the treatment of adrenal metastases, increasingly replacing traditional invasive approaches. However, its clinical application remains under investigation. The introduction of advanced radiotherapy techniques has further fueled interest in SBRT, necessitating comprehensive dosimetric evaluations to optimize treatment strategies. This study compares three distinct SBRT techniques: pure intensity-modulated radiotherapy (IMRT), pure volumetric modulated arc therapy (VMAT), and a hybrid approach combining VMAT and IMRT, utilizing flattening filter-free (FFF) photon beams. Treatment plans were assessed using dosimetric distributions, dose-volume histograms (DVH), homogeneity index (HI), and conformity index (CI). Repeated-measures analysis of variance (ANOVA) was performed, with statistical significance set at p < 0.05. Both VMAT and hybrid plans demonstrated superior CI and HI values compared to IMRT. However, the maximum dose (Dmax) to the planning target volume (PTV) was lower in the hybrid plan than in VMAT but comparable to IMRT. Additionally, critical organ dose analyses revealed that VMAT and hybrid plans achieved significantly lower doses in the renal cortex (Dmax and V17.5), duodenum (Dmax and V12.5), aorta (Dmax), and stomach (Dmax) compared to IMRT. The findings indicate that both VMAT and hybrid techniques outperform IMRT, offering improved plan quality and superior critical organ sparing. These results highlight the potential clinical advantages of VMAT and hybrid SBRT approaches in the treatment of adrenal metastases. Further clinical validation through large-scale studies is warranted to establish the optimal treatment strategy.
- 3 December 2024
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (1) , 1-8
The effect of hand massage on fatigue in women with cancer receiving brachytherapy: randomized clinical trial
Purpose This randomized controlled study was conducted to analyze the effect of hand massage on the fatigue level of the women receiving brachytherapy. Methods It was determined that 12 patients were included in each group (control and hand massage group), so 24 women with gynecologic cancer were included in the study. The application was performed on each hand for 5 min, a total of 10 min in hand massage group. Hand massage was applied before each brachytherapy (at the first, second, and third sessions, a total of three times) every other day for 1 week in the hand massage group. No intervention was performed to the control group during the study. The data were collected using the Patient Information Form and Brief Fatigue Inventory (BFI). Results At the end of the brachytherapy, the fatigue severity score and impact of fatigue on activities of daily living scores of the group that applied hand massage were determined to be lower than the control group (p < 0.05). Conclusion It was determined that hand massage effectively controlled fatigue and the impact of fatigue on activities of daily living. Hand massage is a safe and economical method that can be performed by certified nurses. Trial registration This clinical trial is registered at ClinicalTrials.gov (NCT06056713-09/21/2023).
- 3 December 2024
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (1) , 1-8
The effect of hand massage on fatigue in women with cancer receiving brachytherapy: randomized clinical trial
Purpose This randomized controlled study was conducted to analyze the effect of hand massage on the fatigue level of the women receiving brachytherapy. Methods It was determined that 12 patients were included in each group (control and hand massage group), so 24 women with gynecologic cancer were included in the study. The application was performed on each hand for 5 min, a total of 10 min in hand massage group. Hand massage was applied before each brachytherapy (at the first, second, and third sessions, a total of three times) every other day for 1 week in the hand massage group. No intervention was performed to the control group during the study. The data were collected using the Patient Information Form and Brief Fatigue Inventory (BFI). Results At the end of the brachytherapy, the fatigue severity score and impact of fatigue on activities of daily living scores of the group that applied hand massage were determined to be lower than the control group (p < 0.05). Conclusion It was determined that hand massage effectively controlled fatigue and the impact of fatigue on activities of daily living. Hand massage is a safe and economical method that can be performed by certified nurses. Trial registration This clinical trial is registered at ClinicalTrials.gov (NCT06056713-09/21/2023).
- 4 November 2024
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 194 (1) , 7-18
Evaluation of early cardiotoxicity in HER2-positive breast cancer patients receiving radiotherapy and concurrent trastuzumab
Background Overexpression of human epidermal growth factor receptor 2 (HER-2) is associated with aggressive disease in breast cancer. Trastuzumab and radiotherapy are standard treatments for patients with HER-2 + breast cancer, but they may increase the risk of cardiotoxicity. Aim This study aimed to assess early cardiotoxicity in patients receiving radiotherapy (RT) and concurrent trastuzumab. Method The study included 116 patients with HER-2 + breast cancer who received concurrent treatment with trastuzumab and RT (52 right-side; 64 left-side). Five left ventricular ejection fraction (LVEF) measurements were performed: one before treatment and four subsequent measurements taken at three-month intervals. LVEF was also assessed before (preRT-EF) and after (postRT-EF) radiotherapy. Results The baseline LVEF was 62.27 ± 5.5%, while the 12-month LVEF was 59.8 ± 5.8% (p < 0.05). In subgroups, post-RT LVEF values were significantly lower than pre-RT LVEF values (p < 0.05). No significant difference was found between the reduction in LVEF for patients receiving 50 Gy and 60 Gy doses. Moreover, the contribution of regional lymph node irradiation to the decrease in LVEF could not be demonstrated. A positive correlation was found between the total trastuzumab dose and the decrease in LVEF from preRT to postRT. Additionally, a positive correlation was observed between the total taxane dose and the reduction in LVEF from baseline to 9 months, both in the overall group and in the left breast cancer group. Conclusion In our study,it was found that not only trastuzumab but also taxane-based agents could be cardiotoxic. However, no connection was found between RT doses and the decrease in LVEF.
- 4 November 2024
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 194 (1) , 7-18
Evaluation of early cardiotoxicity in HER2-positive breast cancer patients receiving radiotherapy and concurrent trastuzumab
Background Overexpression of human epidermal growth factor receptor 2 (HER-2) is associated with aggressive disease in breast cancer. Trastuzumab and radiotherapy are standard treatments for patients with HER-2 + breast cancer, but they may increase the risk of cardiotoxicity. Aim This study aimed to assess early cardiotoxicity in patients receiving radiotherapy (RT) and concurrent trastuzumab. Method The study included 116 patients with HER-2 + breast cancer who received concurrent treatment with trastuzumab and RT (52 right-side; 64 left-side). Five left ventricular ejection fraction (LVEF) measurements were performed: one before treatment and four subsequent measurements taken at three-month intervals. LVEF was also assessed before (preRT-EF) and after (postRT-EF) radiotherapy. Results The baseline LVEF was 62.27 ± 5.5%, while the 12-month LVEF was 59.8 ± 5.8% (p < 0.05). In subgroups, post-RT LVEF values were significantly lower than pre-RT LVEF values (p < 0.05). No significant difference was found between the reduction in LVEF for patients receiving 50 Gy and 60 Gy doses. Moreover, the contribution of regional lymph node irradiation to the decrease in LVEF could not be demonstrated. A positive correlation was found between the total trastuzumab dose and the decrease in LVEF from preRT to postRT. Additionally, a positive correlation was observed between the total taxane dose and the reduction in LVEF from baseline to 9 months, both in the overall group and in the left breast cancer group. Conclusion In our study,it was found that not only trastuzumab but also taxane-based agents could be cardiotoxic. However, no connection was found between RT doses and the decrease in LVEF.
- Open Access
- 20 May 2024
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 32 (6) , 1-8
The relationship between quality of life and sex role of women with gynecological cancers undergoing brachytherapy
Purpose: This study aims to analyze the relationship between the quality of life and sex roles of women diagnosed with cancer and undergoing brachytherapy. Methods: The research is a cross-sectional descriptive study. The sample of the study included 116 women over 35 years old who were diagnosed with a gynecologic cancer and underwent intracavitary brachytherapy at the Radiation Oncology Department of a university hospital. Personal information form, SF-36 the Quality of Life Scale, and BEM Sex Role Inventory were used in the study. The researcher collected the data through face-to-face interview. The data were collected in the nurses’ room after 3 different brachytherapy treatments that patients received weekly. Results: It was found that the average score of the physical functioning subscale was 32.80 ± 24.33, the average score of role physical was 15.43 ± 28.78, the average score of role emotional was 17.81 ± 28.96, the average score of vitality was 39.13 ± 16.12, the average score of social functioning was 43.53 ± 20.55, the score average of pain was 50.0 ± 20.09, the average score of general health was 42.67 ± 14.61, and the general health of mental health was 55.86 ± 16.12. In the BEM sex roles scale, the average score of BEM femininity was 105.56 ± 13.95, and the average score of BEM masculinity was 80.61 ± 12.77. In our study, a very low, negative, and significant relationship was determined between the role of femininity and emotional role limitation, physical functionality, social functionality, and general health perception in the women undergoing brachytherapy (p < 0.05). Conclusions: Based on the findings of the present study, we can state that an increase in the “role of femininity” in women undergoing brachytherapy was effective in the decrease in the quality of lives of women. It can be claimed that the results will be a guidance for the nurses who will play an important role in increasing the quality of lives of the women undergoing brachytherapy.
- 20 May 2024
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 32 (6) , 1-8
Open AccessThe relationship between quality of life and sex role of women with gynecological cancers undergoing brachytherapy
Purpose: This study aims to analyze the relationship between the quality of life and sex roles of women diagnosed with cancer and undergoing brachytherapy. Methods: The research is a cross-sectional descriptive study. The sample of the study included 116 women over 35 years old who were diagnosed with a gynecologic cancer and underwent intracavitary brachytherapy at the Radiation Oncology Department of a university hospital. Personal information form, SF-36 the Quality of Life Scale, and BEM Sex Role Inventory were used in the study. The researcher collected the data through face-to-face interview. The data were collected in the nurses’ room after 3 different brachytherapy treatments that patients received weekly. Results: It was found that the average score of the physical functioning subscale was 32.80 ± 24.33, the average score of role physical was 15.43 ± 28.78, the average score of role emotional was 17.81 ± 28.96, the average score of vitality was 39.13 ± 16.12, the average score of social functioning was 43.53 ± 20.55, the score average of pain was 50.0 ± 20.09, the average score of general health was 42.67 ± 14.61, and the general health of mental health was 55.86 ± 16.12. In the BEM sex roles scale, the average score of BEM femininity was 105.56 ± 13.95, and the average score of BEM masculinity was 80.61 ± 12.77. In our study, a very low, negative, and significant relationship was determined between the role of femininity and emotional role limitation, physical functionality, social functionality, and general health perception in the women undergoing brachytherapy (p < 0.05). Conclusions: Based on the findings of the present study, we can state that an increase in the “role of femininity” in women undergoing brachytherapy was effective in the decrease in the quality of lives of women. It can be claimed that the results will be a guidance for the nurses who will play an important role in increasing the quality of lives of the women undergoing brachytherapy.
- Open Access
- 20 February 2024
- Published by Springer Nature in Research Square
Treatment Patterns and Prognostic Factors in Stage I-III Male Breast Cancer: Multicentric Study of Turkish Socİety for Radİatİon Oncology Breast Cancer Study Group (Trod 06-013)
Aim Clinicopathologic,demographic characteristics, and treatment patterns of patients diagnosed with male breast cancer (MBC) and treated with adjuvant radiotherapy (RT) in the last 20 years were retrospectively analyzed. Material and Method: Between January 2000 and January 2021, 207 patients diagnosed with MBC, all of whom underwent RT, were recruited from 25 centers.Kaplan-Meier method was used to determine the rates of overall survival (OS),progression-free survival (PFS),and loco-regional recurrence-free survival(LRRFS).Multivariate Cox regression analysis was used to determine the relationship between histopathologic data and survival and prognostic factors. Results Estrogen receptor (ER) was positive in 93% and progesterone receptor (PR) in 83.4% patients.Human epidermal growth factor 2 (HER2) was negative in 75.4%.In multivariate analysis; > 5 cm tumor, > 50 years of age, pathological lymph node stage(pN) as pN2 or pN3, pathological tumor stage (pT) as pT3 or pT4, TNM stage III, nipple invasion, skin invasion, and ER negativity was related with shortened OS.These prognostic factors for PFS and LRRFS were similar except ER status.There was no difference in survival rates between pN0 and pN1 groups nor pT1 and pT2 groups.OS and LRRFS were longer in patients treated with endocrine therapy (ET). However,there was no difference between the tamoxifen (TMX) group and the aromatase inhibitor (AI) + luteinizing hormone-releasing hormone agonist (LHRH-a) group (p > 0.05). Conclusion The most important poor prognostic factors in MBC were tumor size exceeding 5 cm,pN2 and above, and age > 50 years at first diagnosis.We also found that adjuvant ET was beneficial for survival,but there was no difference between the AI and TMX groups.
- 20 February 2024
- Published by Springer Nature in Research Square
Open AccessTreatment Patterns and Prognostic Factors in Stage I-III Male Breast Cancer: Multicentric Study of Turkish Socİety for Radİatİon Oncology Breast Cancer Study Group (Trod 06-013)
Aim Clinicopathologic,demographic characteristics, and treatment patterns of patients diagnosed with male breast cancer (MBC) and treated with adjuvant radiotherapy (RT) in the last 20 years were retrospectively analyzed. Material and Method: Between January 2000 and January 2021, 207 patients diagnosed with MBC, all of whom underwent RT, were recruited from 25 centers.Kaplan-Meier method was used to determine the rates of overall survival (OS),progression-free survival (PFS),and loco-regional recurrence-free survival(LRRFS).Multivariate Cox regression analysis was used to determine the relationship between histopathologic data and survival and prognostic factors. Results Estrogen receptor (ER) was positive in 93% and progesterone receptor (PR) in 83.4% patients.Human epidermal growth factor 2 (HER2) was negative in 75.4%.In multivariate analysis; > 5 cm tumor, > 50 years of age, pathological lymph node stage(pN) as pN2 or pN3, pathological tumor stage (pT) as pT3 or pT4, TNM stage III, nipple invasion, skin invasion, and ER negativity was related with shortened OS.These prognostic factors for PFS and LRRFS were similar except ER status.There was no difference in survival rates between pN0 and pN1 groups nor pT1 and pT2 groups.OS and LRRFS were longer in patients treated with endocrine therapy (ET). However,there was no difference between the tamoxifen (TMX) group and the aromatase inhibitor (AI) + luteinizing hormone-releasing hormone agonist (LHRH-a) group (p > 0.05). Conclusion The most important poor prognostic factors in MBC were tumor size exceeding 5 cm,pN2 and above, and age > 50 years at first diagnosis.We also found that adjuvant ET was beneficial for survival,but there was no difference between the AI and TMX groups.